Efficacy of atezolizumab/bevacizumab combination therapy in BCLC-C cirrhotic patients with hepatocellular carcinoma (HCC) according to the type of disease progression.

Citation:

Pantzios S, Syriha A, Mandilara D, Stathopoulou I, Barla G, Galanis P, Elelfsiniotis I. Efficacy of atezolizumab/bevacizumab combination therapy in BCLC-C cirrhotic patients with hepatocellular carcinoma (HCC) according to the type of disease progression. 2023.

Contact Details

National and Kapodistrian University of Athens
(+30) 210-7461471
123 Papadiamantopoulou street
Athens, 11527
pegalan@nurs.uoa.gr

Recent Publications

" Case-control" studies A brief history from the" abstain from beans" of Pythagoras to the present
Stratified analysis of data
Fundamental principles of epidemiological data analysis

Submitted (39)
2023 (38)
2022 (53)
2021 (9)
2020 (28)
2019 (38)
2018 (43)
2017 (36)
2016 (45)
2015 (31)

Petros Galanis

Assistant Professor, Nursing

Efficacy of atezolizumab/bevacizumab combination therapy in BCLC-C cirrhotic patients with hepatocellular carcinoma (HCC) according to the type of disease progression.

Citation:

Contact Details

Recent Publications

Publications per year